Phase I/II Safety and Tolerability Study of striatal administration of BV-101 in adult subjects with Early Manifest Huntington's Disease (HD) Phase I/II Safety and Tolerability Study of striatal administration of BV-101 in adult subjects with ...
An Open-Label Phase I/II Dose Finding Study to evaluate the Safety, Tolerability, and Preliminary Efficacy of Striatal Administration of BV-101 in Adult Subjects with Early Manifest Huntington's Disease (HD) An Open-Label Phase I/II Dose Finding Study to evaluate the Safety, Tolerability, and Preliminary Ef ...